BR112014019196A8 - Método para síntese estereosseletiva de 9-hidróxi-5-oxo-1,4-diaza-espiro[5.5]undecanos 1,4-protegidos - Google Patents

Método para síntese estereosseletiva de 9-hidróxi-5-oxo-1,4-diaza-espiro[5.5]undecanos 1,4-protegidos

Info

Publication number
BR112014019196A8
BR112014019196A8 BR112014019196A BR112014019196A BR112014019196A8 BR 112014019196 A8 BR112014019196 A8 BR 112014019196A8 BR 112014019196 A BR112014019196 A BR 112014019196A BR 112014019196 A BR112014019196 A BR 112014019196A BR 112014019196 A8 BR112014019196 A8 BR 112014019196A8
Authority
BR
Brazil
Prior art keywords
formula
compound
stereosesective
undecanes
diaza
Prior art date
Application number
BR112014019196A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112014019196A2 (https=
Inventor
Schnaubelt Juergen
Tang Wenjun
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BR112014019196A2 publication Critical patent/BR112014019196A2/pt
Publication of BR112014019196A8 publication Critical patent/BR112014019196A8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/113Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
BR112014019196A 2012-02-09 2013-02-06 Método para síntese estereosseletiva de 9-hidróxi-5-oxo-1,4-diaza-espiro[5.5]undecanos 1,4-protegidos BR112014019196A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12154688 2012-02-09
PCT/EP2013/052287 WO2013117568A1 (de) 2012-02-09 2013-02-06 Verfahren zur stereoselektiven synthese von 1,4-geschützten 9-hydroxy-5-oxo-1,4-diaza-spiro [5.5] undecane

Publications (2)

Publication Number Publication Date
BR112014019196A2 BR112014019196A2 (https=) 2017-06-20
BR112014019196A8 true BR112014019196A8 (pt) 2017-07-11

Family

ID=47678813

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014019196A BR112014019196A8 (pt) 2012-02-09 2013-02-06 Método para síntese estereosseletiva de 9-hidróxi-5-oxo-1,4-diaza-espiro[5.5]undecanos 1,4-protegidos

Country Status (14)

Country Link
US (1) US8629146B2 (https=)
EP (1) EP2812317B1 (https=)
JP (1) JP6105631B2 (https=)
KR (1) KR20140128318A (https=)
CN (1) CN104080775A (https=)
AU (1) AU2013218119A1 (https=)
BR (1) BR112014019196A8 (https=)
CA (1) CA2862520A1 (https=)
CL (1) CL2014001823A1 (https=)
EA (1) EA201400882A1 (https=)
IL (1) IL233370A (https=)
MX (1) MX2014009033A (https=)
PH (1) PH12014501760A1 (https=)
WO (1) WO2013117568A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2289881A1 (de) * 2009-08-06 2011-03-02 Boehringer Ingelheim International GmbH Verfahren zur stereoselektiven Synthese bicyclischer Heterocyclen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4575507A (en) * 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
CA2476008C (en) 2002-03-30 2011-12-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
US6924285B2 (en) 2002-03-30 2005-08-02 Boehringer Ingelheim Pharma Gmbh & Co. Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
BRPI0619603A2 (pt) 2005-12-12 2011-10-11 Boehringer Ingelheim Int heterociclos bicìclicos, sais fisiologicamante compatìveis, medicamentos que contêm esses compostos, bem como uso e processos para produção dos heterociclos bicìclicos
CA2711582A1 (en) 2008-02-07 2009-08-13 Boehringer Ingelheim International Gmbh Spirocyclic heterocycles, formulations containing said compounds, use thereof and processes for the preparation thereof
EP2289881A1 (de) 2009-08-06 2011-03-02 Boehringer Ingelheim International GmbH Verfahren zur stereoselektiven Synthese bicyclischer Heterocyclen
EA023573B1 (ru) 2011-02-01 2016-06-30 Бёрингер Ингельхайм Интернациональ Гмбх Дималеат 9-[4-(3-хлор-2-фторфениламино)-7-метоксихиназолин-6-илокси]-1,4-диазаспиро[5.5]ундекан-5-она, его применение в качестве лекарственного средства и его получение

Also Published As

Publication number Publication date
CA2862520A1 (en) 2013-08-15
EP2812317B1 (de) 2016-02-03
JP2015506966A (ja) 2015-03-05
PH12014501760B1 (en) 2014-11-10
CL2014001823A1 (es) 2015-03-06
MX2014009033A (es) 2014-10-17
CN104080775A (zh) 2014-10-01
EA201400882A1 (ru) 2015-01-30
US8629146B2 (en) 2014-01-14
PH12014501760A1 (en) 2014-11-10
EP2812317A1 (de) 2014-12-17
IL233370A (en) 2015-04-30
KR20140128318A (ko) 2014-11-05
AU2013218119A1 (en) 2014-07-17
US20130211081A1 (en) 2013-08-15
JP6105631B2 (ja) 2017-03-29
BR112014019196A2 (https=) 2017-06-20
IL233370A0 (en) 2014-08-31
WO2013117568A1 (de) 2013-08-15

Similar Documents

Publication Publication Date Title
MX350809B (es) Derivados nucleósidos con sustitución 2',4'-difluoro-2'-metilo como inhibidores de la replicación del arn del vhc.
BR112015001608A2 (pt) inibidor lfa-1 e polimorfo do mesmo
BR112014018756A8 (pt) Processo para preparo de etil éster de ácido n-(4-ciclo-hexil-3-trifluorometil-benziloxi)-acetimídico
MY182428A (en) Crystalline forms of a prolyl hydroxylase inhibitor
MX2010007587A (es) Compuestos que comprenden un grupo ciclobutoxi.
BR112012019762A2 (pt) composto, composição, e, método para tratar uma doença.
BR112015001839A2 (pt) ibrutinibe deuterado
MX350810B (es) Derivados de los nucleosidos sustituidos en 4 '-azido, 3 '-fluoro como inhibidores de la replicacion del rna del vhc.
PH12015500211B1 (en) 4-methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes
BR112013011593A2 (pt) cristal de derivado de morfinan 7-carbamoíla-6,7-insaturada e método para produzir o mesmo
BR112013016578A2 (pt) processo para preparar metilmercaptopropionaldeídeo
CR20180412A (es) Proceso para preparar compuestos antivirales
BR112012031340A2 (pt) derivados de cianoquinolina
WO2012031045A3 (en) Phosphonate ester derivatives and methods of synthesis thereof
BR112012027625A2 (pt) ligante para refratários monolíticos, refratário monolítico, e método de construção de refratários monolíticos
BR112015029504A2 (pt) inibidores quinase
EA201300647A1 (ru) Оптимизированный синтез чистых неполиморфных кристаллических жёлчных кислот с заданным размером частиц
MX2011009898A (es) Proceso para la obtencion de derivados de acido propionico.
BR112014009266A8 (pt) processos encurtado, biocatalítico e para preparação de ácidos isoxazolil-metóxi-nicotínicos
MX2013000294A (es) Intermedios y procedimiento de preparación de un inhibidor específico de la trombina.
HUE040484T2 (hu) Eljárás (3S,3S')4,4'-diszulfándiilbisz(3-aminobután-1-szulfonsav) elõállítására
BR112012017485A2 (pt) derivados de ácido carboxílico tendo um anel de oxazolpirimidina 2.5.7-substituído
BR112014019196A8 (pt) Método para síntese estereosseletiva de 9-hidróxi-5-oxo-1,4-diaza-espiro[5.5]undecanos 1,4-protegidos
UA118269C2 (uk) Промисловий спосіб синтезу уліпристалу ацетату і його 4'-ацетильного аналога
GB2523674A (en) Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]